Pharmena S.A. (PHR) — Strategic Asset Allocation Index
Pharmena S.A. (PHR) has a Strategic Asset Allocation Index of 1.3% as of September 2022. Strategic assets (PP&E of zł577.00K plus long-term investments of zł-) total zł577.00K, measured against net assets of zł44.42 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Pharmena S.A. (PHR) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Pharmena S.A. Strategic Asset Allocation Index (2015–2019)
This chart shows how Pharmena S.A.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2015 to 2019. As of September 2022, the index stands at 1.3%, representing strategic assets of zł577.00K against net assets of zł44.42 Million PLN. For live market cap and overall valuation, see Pharmena S.A. (PHR) market capitalisation.
Annual Strategic Asset Allocation Index for Pharmena S.A. (2015–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Pharmena S.A. from 2015 to 2019, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See PHR net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 11.0% | zł550.00K | zł550.00K | zł- | zł5.00 Million | ▲ +2.1 pp |
| 2018 | 8.9% | zł172.00K | zł172.00K | zł- | zł1.94 Million | ▲ +4.0 pp |
| 2017 | 4.9% | zł175.00K | zł175.00K | zł- | zł3.56 Million | ▲ +0.4 pp |
| 2016 | 4.5% | zł268.00K | zł268.00K | zł- | zł5.94 Million | ▲ +2.1 pp |
| 2015 | 2.4% | zł208.00K | zł208.00K | zł- | zł8.67 Million | — |